Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05339412 · ClinicalTrials.gov registry record · NA
Technology-based Training Tool for PHAT Life
A NA study of HIV Infection and Sexually Transmitted Infections, sponsored by Oregon Research Behavioral Intervention Strategies.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT05339412: Completed NA study of HIV Infection and Sexually Transmitted Infections, sponsored by Oregon Research Behavioral Intervention Strategies.
NCT05339412 is a NA study of HIV Infection and Sexually Transmitted Infections that has completed, run by Oregon Research Behavioral Intervention Strategies. The registered enrollment target is 24 participants, below the 242-participant average among 73 other HIV Infection trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05339412, a NA study of HIV Infection and Sexually Transmitted Infections, has completed, sponsored by Oregon Research Behavioral Intervention Strategies.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
Youth under age 18 involved in the criminal justice system are disproportionately minorities \& affected by substance abuse, mental illness, \& HIV/STI. Most young offenders are released on community supervision without the STI, mental health, or substance use screening, diagnosis, \& treatment afforded detained youth, despite similar rates of risk behavior. Their long-term trajectory is poor, costs to society are high, \& lasting effects on community well-being \& individual employment prospects are profound. Altering this trajectory is a public health priority. Preventing HIV Among Teens (PHAT) Life is an evidence-based program that meets the need in juvenile justice to address youths' co-morbid health problems. The next step in ensuring that this decade-long line of research produces actual, real-world improvements in the lives of probation youth is to develop a PHAT Life training strategy that is effective, cost-effective, \& sustainable within juvenile justice settings. The private/public collaboration between ORBIS \& UIC will leverage existing resources \& competencies to create a commercially viable technology-based training tool for PHAT Life with great potential for sustainability \& cost-effectiveness. This Phase II uses a formative process to refine, enhance \& complete the technology-based training tool to include: (a) an interactive multimedia web browser \& mobile application, (b) dynamic multimedia presentations \& interactive queries, (c) video examples of mock intervention delivery, (d) audio narration along with scripted language, (e) brief quizzes to ensure comprehension \& knowledge acquisition, (f) opportunities to "learn more" by clicking on tabs for supplemental information, (g) targeted referrals to appendix materials, (h) games to promote engagement, \& (i) other adaptations based on Phase I feedback. The proposed technology-based training tool should be highly sustainable, because it (a) relies on "indigenous" personnel to deliver the inte
Primary Outcome
The Human Immunodeficiency Virus Knowledge Questionnaire (HIV-KQ) is an 12-item true/false measure developed to assess knowledge needed for HIV prevention. Total scores are calculated by the number of correct items. The minimum score is "0" and the maximum score is "12". A higher score indicate higher HIV knowledge.
Conditions Studied
Interventions
- BEHAVIORAL Training Tool for Preventing HIV/AIDS among Teens (PHAT) Life
Study Locations (1)
Oregon
- Oregon Research Behavioral Intervention Strategies, Inc. - Springfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2024-01-26 |
| Est. Completion | 2024-12-20 |
| Phase | NA |
What the finished NCT05339412 record still lists
NCT05339412 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 242-participant average among 73 other HIV Infection trials with a reported enrollment target (90% lower).
The record links to 3 conditions, with HIV Infection appearing as the primary indexed condition, and to 1 intervention - of which Training Tool for Preventing HIV/AIDS among Teens (PHAT) Life is the first listed.
NCT05339412 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT05339412 about?
NCT05339412 is a clinical study titled "Technology-based Training Tool for PHAT Life". Youth under age 18 involved in the criminal justice system are disproportionately minorities \& affected by substance abuse, mental illness, \& HIV/STI. Most young offenders are released on community supervision without the STI, mental health, or substance use screening, diagnosis, \& treatment affo...
What is the current status of trial NCT05339412?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2024-01-26. Estimated completion is 2024-12-20.
What conditions does trial NCT05339412 study?
This clinical trial studies the following conditions: HIV Infection, Sexually Transmitted Infections, Implementation.
What interventions are being tested in trial NCT05339412?
The interventions under investigation include: Training Tool for Preventing HIV/AIDS among Teens (PHAT) Life (BEHAVIORAL).
Who is sponsoring clinical trial NCT05339412?
This trial is sponsored by Oregon Research Behavioral Intervention Strategies, which has 21 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05339412 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05339412's enrollment target sits among peer trials
24 59th of 73 higher than 15 of 73 other HIV Infection trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Infection trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
HIV+ Deceased Donor Heart Transplant Study for HIV+ Recipients
RECRUITING · NA
-
Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study
RECRUITING · NA
-
Suubi-Mhealth: A Mobile Health Intervention to Address Depression Among Youth
RECRUITING · NA
-
The Role of the Gastrointestinal-associated Lymphoid Tissue in the Cure of HIV Infection
RECRUITING · NA
-
Anal Cytology Collection Procedures in Predicting High-Grade Anal Dysplasia in Men Who Have Sex With Men
ACTIVE NOT RECRUITING · NA
-
Physician Focused Intervention to Improve Adherence With HIV Antiretrovirals
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI